These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34893936)

  • 21. The effect of surfactants on the dissolution behavior of amorphous formulations.
    Mah PT; Peltonen L; Novakovic D; Rades T; Strachan CJ; Laaksonen T
    Eur J Pharm Biopharm; 2016 Jun; 103():13-22. PubMed ID: 26955750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
    Newman A; Reutzel-Edens SM; Zografi G
    J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supersaturation and phase behavior during dissolution of amorphous solid dispersions.
    Kong Y; Wang W; Wang C; Li L; Peng D; Tian B
    Int J Pharm; 2023 Jan; 631():122524. PubMed ID: 36549404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical stability of amorphous pharmaceutical solids: Nucleation, crystal growth, phase separation and effects of the polymers.
    Shi Q; Li F; Yeh S; Wang Y; Xin J
    Int J Pharm; 2020 Nov; 590():119925. PubMed ID: 33011255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
    Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S; Rudraraju VS
    AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
    Peng R; Huang J; He L; Zhao L; Wang C; Wei W; Xia T; Mao Y; Wen Y; Wang L; Yang J
    Eur J Pharm Sci; 2020 Apr; 146():105262. PubMed ID: 32060005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
    Li Y; Rantanen J; Yang M; Bohr A
    Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR; Lee PI
    Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
    Sun DD; Lee PI
    AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Solid State NMR Investigation for Molecular States of Specialized Formulation to Improve the Water Solubility of Poorly Water-soluble Drugs].
    Higashi K
    Yakugaku Zasshi; 2021; 141(9):1063-1069. PubMed ID: 34471007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M; Visti M; Ojarinta R; Laitinen R
    Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
    Hurley D; Potter CB; Walker GM; Higginbotham CL
    J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparative Study of the Pharmaceutical Properties between Amorphous Drugs Loaded-Mesoporous Silica and Pure Amorphous Drugs Prepared by Solvent Evaporation.
    Budiman A; Aulifa DL
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.